Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yilei Mao

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
Healthcare (Basel, Switzerland)|January 8, 2023
Artificial Intelligence in NAFLD: Will Liver Biopsy Still Be Necessary in the Future?Lei Zhang, Yilei Mao
Annals of Translational Medicine|December 7, 2019
Magnesium and liver diseaseMeixi Liu, Huayu Yang, Yilei Mao
Annals of Translational Medicine|February 5, 2020
Programmed cell death protein 1/programmed death ligand-1 checkpoint blockade meets patient-derived organoidsLejia Sun, Huayu Yang, Yilei Mao
Gut|August 21, 2020
Response letter to: letter to the editor: three-dimensional bioprinted hepatorganoids in liver failureHuayu Yang, Lejia Sun, Yilei Mao
Current Pharmaceutical Design|March 7, 2023
Time-restricted Feeding Changes as Inspiration for Drug DesignZhangyuting He, Huayu Yang, Yilei Mao
Frontiers in Pharmacology|May 22, 2023
Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineeringHang Sun, Huayu Yang, Yilei Mao
Annals of Translational Medicine|December 7, 2019
Portal pressure monitoring-state-of-the-art and future perspectiveGang Xu, Fei Li, Yilei Mao
Clinics and Research in Hepatology and Gastroenterology|June 24, 2022
Letter to the editor: Liver transarterial chemoembolization plus sunitinib for unresectable hepatocellular carcinomaZhiyuan Fang, Huayu Yang, Yilei Mao
Journal of Hepatology|December 19, 2020
The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLDMeixi Liu, Lejia Sun, Yilei Mao
Annals of Translational Medicine|February 12, 2019
The role of exosomes in tumor immunityHuayu Yang, Lejia Sun, Yilei Mao
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Healthcare (Basel, Switzerland)|January 8, 2023
Artificial Intelligence in NAFLD: Will Liver Biopsy Still Be Necessary in the Future?Lei Zhang, Yilei Mao
Annals of Translational Medicine|December 7, 2019
Magnesium and liver diseaseMeixi Liu, Huayu Yang, Yilei Mao
Annals of Translational Medicine|February 5, 2020
Programmed cell death protein 1/programmed death ligand-1 checkpoint blockade meets patient-derived organoidsLejia Sun, Huayu Yang, Yilei Mao
Gut|August 21, 2020
Response letter to: letter to the editor: three-dimensional bioprinted hepatorganoids in liver failureHuayu Yang, Lejia Sun, Yilei Mao
Current Pharmaceutical Design|March 7, 2023
Time-restricted Feeding Changes as Inspiration for Drug DesignZhangyuting He, Huayu Yang, Yilei Mao
Frontiers in Pharmacology|May 22, 2023
Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineeringHang Sun, Huayu Yang, Yilei Mao
Annals of Translational Medicine|December 7, 2019
Portal pressure monitoring-state-of-the-art and future perspectiveGang Xu, Fei Li, Yilei Mao
Clinics and Research in Hepatology and Gastroenterology|June 24, 2022
Letter to the editor: Liver transarterial chemoembolization plus sunitinib for unresectable hepatocellular carcinomaZhiyuan Fang, Huayu Yang, Yilei Mao
Journal of Hepatology|December 19, 2020
The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLDMeixi Liu, Lejia Sun, Yilei Mao
Annals of Translational Medicine|February 12, 2019
The role of exosomes in tumor immunityHuayu Yang, Lejia Sun, Yilei Mao
Pageof 21